Breaking the Health Company Compliance Program Monopoly - McDermott Will & Emery

Breaking the Health Company Compliance Program Monopoly

Overview


Michael Peregrine and Stephen Wu wrote this bylined article cautioning that, while healthcare organization compliance programs must focus on fraud and abuse, self-referral and reimbursement rules, “that sensitivity should not lead to, nor justify, marginal program emphasis on compliance with other laws enforced by health industry regulators.” The authors called for a “balanced” compliance program that covers “renewed federal enforcement of individual and corporate violations of the antitrust laws.”

Read the full article.